TL;DR
This paper tackles the challenge of understanding the dynamic interaction between RAD51 and the BRCA2 BRC4 repeat, crucial for DNA repair. By integrating advanced molecular simulations with experimental data (SAXS, XL-MS), they reconstruct the conformational ensemble of this complex, revealing key residues and dynamics that could be targeted for cancer therapies.
What Problem Does This Paper Address?
Homologous recombination (HR) is a vital DNA repair pathway, and the interaction between RAD51 and BRCA2 is a critical early step. BRCA2 recruits RAD51 through its BRC repeats, but the full picture of how the entire RAD51 protein interacts with a BRC repeat, particularly the BRC4 repeat, remains elusive. Existing structural data is limited, especially concerning the flexible N-terminal domain of RAD51, which is thought to be involved in this interaction. This knowledge gap hinders our understanding of how RAD51 is recruited to DNA damage sites and limits the development of targeted therapies.
Methods
The study employs a multi-pronged approach:
- AlphaFold2: Used to generate an initial structural model of the full-length RAD51-BRC4 complex, providing a starting point for simulations.
- Steered Molecular Dynamics (SMD): Employed to refine the initial AlphaFold2 model by driving it towards compatibility with experimental SAXS data. Crucially, this step highlighted the importance of including solvent effects in the SAXS calculation model (SB-hySAXS scheme) to prevent artificial detachment of BRC4 from RAD51.
- Metadynamics Simulations: Used to explore the conformational landscape of the RAD51-BRC4 complex, guided by the SAXS-consistent single-structure model from SMD. These simulations were further constrained by experimental cross-linking mass spectrometry (XL-MS) data, which provided distance restraints between specific residues.
- Maximum Entropy Reweighting (Maxent): Applied to refine the ensemble of conformations generated by metadynamics, ensuring consistency with experimental SAXS data. This method assigns weights to different conformations to best match the observed scattering patterns.
- Cross-linking Mass Spectrometry (XL-MS): Used to experimentally identify specific residue-residue contacts between RAD51 and BRC4, providing crucial validation and constraints for the simulations.
- Small-Angle X-ray Scattering (SAXS): Experimental data used to guide the simulations and validate the final conformational ensemble.
Datasets
- SAXS Data: Experimental SAXS data for the RAD51-BRC4 complex was obtained from the Small Angle Scattering Biological Data Bank (SASBDB) under accession code SASDQT9.
- XL-MS Data: Newly acquired XL-MS data was generated as part of this study.
- AlphaFold2 Predictions: Models were generated using AlphaFold2.
Key Insights and Ideas
- Solvent is Crucial: The inclusion of solvent effects in SAXS calculations (SB-hySAXS scheme) was essential for obtaining a SAXS-consistent single-structure model and preventing artificial dissociation of the complex during simulations. This highlights the often-overlooked importance of solvation in accurately modeling protein-ligand interactions.
- Dynamic Ensemble, Not a Single Structure: The RAD51-BRC4 complex exists as a dynamic equilibrium between compact and elongated conformations, rather than a single static structure. This ensemble view is critical for understanding its function.
- N-terminus Flexibility is Key: The interaction with BRC4 appears to induce a rearrangement and increased flexibility in RAD51's N-terminal domain, which is crucial for its functional role.
- Charged Residues as Anchors: Specific charged residues at the N-ter-BRC4 interface, particularly Lys59 of RAD51 and Glu38/Gln39 of BRC4, form persistent contacts that stabilize compact conformations.
- BRC4 as a Depolymerization Agent: The BRC4 repeat, through its FXXA and LFDE domains, appears to play a role in preventing RAD51 oligomerization by hindering the formation of key interfaces, thus facilitating RAD51 translocation as a monomer.
Key Results
- The study successfully reconstructed a SAXS-compliant conformational ensemble of the full-length RAD51-BRC4 complex in solution.
- XL-MS identified four high-quality interprotein cross-links, specifically between Lys59, Lys65, and Lys71 of RAD51's N-terminus and Lys1536 and Lys1541 of BRC4.
- The reweighted ensemble showed a shift towards more extended conformations compared to the initial metadynamics simulation, with 65% extended and 35% compact structures.
- Contact analysis revealed that charged and polar residues, especially Lys59 (RAD51) and Glu38/Gln39 (BRC4), are central to the N-ter-BRC4 interface.
Limitations and Future Work
- Experimental Data Limitations: While the study integrates experimental data, the resolution of SAXS and XL-MS can limit the precision of structural information.
- AlphaFold2 as a Starting Point: AlphaFold2 provides a good initial guess, but its predictions are not always perfect and require experimental validation and refinement through simulations.
- Future Work: The authors suggest that this work provides a foundation for developing novel binders targeting the BRC4 site to modulate RAD51 activity, potentially leading to new anticancer agents. Further investigation into how other BRC repeats interact with RAD51 and how mutations in these interaction sites affect HR is also implied.
Summary updated